Skip to main content
. Author manuscript; available in PMC: 2024 Apr 17.
Published in final edited form as: Bone. 2021 Dec 8;156:116289. doi: 10.1016/j.bone.2021.116289

Fig. 13.

Fig. 13.

Percentage urinary excretion of bisphosphonates collected 24 h after i.v. injection (multiple compounds were administered in the same injection) (adapted from ref. [108]). Higher affinity compounds have a lower recovery in the urine. AF647-RIS (compound 52a6 in Fig. 17) & FAM-RIS (compound 52a1 in Fig. 17) are fluorescently labeled bisphosphonates [109,110].